کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5527480 1547725 2017 9 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Retinoic acid, CYP26, and drug resistance in the stem cell niche
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی تحقیقات سرطان
پیش نمایش صفحه اول مقاله
Retinoic acid, CYP26, and drug resistance in the stem cell niche
چکیده انگلیسی


- The bone marrow microenvironment metabolizes retinoids via CYP26 and creates low-retinoid niches.
- Normal hematopoietic stem cells (HSCs) are protected in these low-retinoid BM niches.
- Malignant HSCs hijack these niches and evade chemotherapy.
- Malignant clones reinforce these niches via increased expression of CYP26.
- Similar mechanisms protect solid tumor cells metastatic to the bone.

The bone marrow niche is essential for hematopoietic stem cells to maintain lifelong blood production by balancing their self-renewal and differentiation. Hematologic malignancies have a similar hierarchical organization to their normal counterparts, with rare populations of cancer stem cells that rely on the microenvironment to survive and propagate their differentiated malignant progenitor cells. Cancer cells alter their microenvironment to create a supportive niche, where they endure chemotherapy, survive as minimal residual disease (MRD), and eventually prevail at relapse. Powerful morphogens, such as retinoids, Wnt/βcatenin, Notch, and Hedgehog, control stem cell fates across tissues, including normal and malignant hematopoiesis. The molecular conversations between these pathways and the mechanisms that control their activity and create gradients at cellular scale remain a mystery. Here, we discuss accumulating evidence suggesting that cytochrome P450 (CYP26), the primary retinoid-inactivating enzyme, plays a critical role in the integration of two of these molecular programs: the retinoid and Hedgehog pathways. Induction of stromal CYP26 by either one of these pathways limits retinoic acid concentration in the stem cell niche, with profound effects on tissue homeostasis and drug resistance. Bypassing this gatekeeping mechanism holds promise for overcoming drug resistance and improving clinical outcomes in hematological malignancies and cancer in general.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Experimental Hematology - Volume 54, October 2017, Pages 17-25
نویسندگان
, , ,